📰 Abt News
Page 26 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
February 21, 2024
Citizens Financial Group Inc. RI lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.6% during the 3rd quarter, Holdings Channel reports. The firm owned 23,783 shares of the healthcare product maker’s stock after selling 889 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in Abbott Laboratories were worth $2,303,000 at […]
February 21, 2024
Rice Partnership LLC trimmed its position in Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 27,846 shares of the healthcare product maker’s stock after selling 1,398 shares during the period. Rice Partnership LLC’s holdings in Abbott Laboratories […]
February 21, 2024
Rice Partnership LLC lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 4.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,846 shares of the healthcare product maker’s stock after selling 1,398 shares during the period. Rice Partnership LLC’s holdings in Abbott Laboratories were […]
February 20, 2024
Rodgers Brothers Inc. boosted its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 150,008 shares of the healthcare product maker’s stock after buying an additional 9,771 shares during the […]
February 20, 2024
Arcblock (ABT) traded up 0.5% against the US dollar during the 1-day period ending at 11:00 AM Eastern on February 20th. One Arcblock token can now be bought for approximately $1.08 or 0.00002090 BTC on major exchanges. Arcblock has a market cap of $106.34 million and $1.58 million worth of Arcblock was traded on exchanges […]
February 20, 2024
Mariner LLC lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,157,958 shares of the healthcare product maker’s stock after selling 15,204 shares during the period. Mariner LLC owned 0.07% of […]
February 20, 2024
Mariner LLC cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,157,958 shares of the healthcare product maker’s stock after selling 15,204 shares during the quarter. Mariner LLC’s […]
February 19, 2024
Rathbones Group PLC boosted its position in Abbott Laboratories (NYSE:ABT – Free Report) by 9.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,137,574 shares of the healthcare product maker’s stock after buying an additional 183,803 shares during the […]
February 18, 2024
Columbia Asset Management lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 18.7% during the third quarter, HoldingsChannel reports. The institutional investor owned 5,641 shares of the healthcare product maker’s stock after selling 1,300 shares during the period. Columbia Asset Management’s holdings in Abbott Laboratories were worth $546,000 as of its most recent […]
February 18, 2024
Columbia Asset Management trimmed its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 18.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,641 shares of the healthcare product maker’s stock after selling 1,300 shares during the quarter. Columbia Asset […]